Works matching DE "PHARMACEUTICAL industry %26 ethics"

Results: 80

Pharmaceutical representatives' beliefs and practices about their professional practice: a study in Sudan.

Published in:

Eastern Mediterranean Health Journal, 2012, v. 18, n. 8, p. 821, doi. 10.26719/2012.18.8.821

By:

Idris, K. M.;
Mustafa, A. F.;
Yousif, M. A.

Publication type:

Article

Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the Former United Nations Special Rapporteur (2002-2008).

Published in:

PLoS Medicine, 2010, v. 7, n. 9, p. 1, doi. 10.1371/journal.pmed.1000330

By:

Hunt, Paul;
Khosla, Rajat

Publication type:

Article

Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving Toward Assessment.

Published in:

PLoS Medicine, 2010, v. 7, n. 9, p. 1, doi. 10.1371/journal.pmed.1000310

By:

Gruskin, Sofia;
Raad, Zyde

Publication type:

Article

Drug patents and intellectual property rights.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 4, p. 403, doi. 10.1007/s00228-015-1811-5

By:

Raj, Gerard;
Priyadarshini, Rekha;
Mathaiyan, Jayanthi

Publication type:

Article

President's Message. Teething Tablet Controversy.

Published in:

American Journal of Homeopathic Medicine, 2016, v. 109, n. 11, p. 5

By:

Whitmont, Ronald D.

Publication type:

Article

Grand Rounds.

Published in:

American Journal of Homeopathic Medicine, 2016, v. 109, n. 6, p. 7

By:

Saltzman, Susanne

Publication type:

Article

Grand Rounds.

Published in:

American Journal of Homeopathic Medicine, 2016, v. 109, n. 6, p. 7

By:

Angell, Marcia

Publication type:

Article

Unpredictable Drug Shortages: An Ethical Framework for Short-Term Rationing in Hospitals.

Published in:

American Journal of Bioethics, 2012, v. 12, n. 1, p. 1, doi. 10.1080/15265161.2011.634483

By:

Rosoff, PhilipM.

Publication type:

Article

PhRMA's Code on Interactions With Healthcare Professionals.

Published in:

2010

By:

Bieri, Diane

Publication type:

Opinion

All Gifts Large and Small: Toward an Understanding of the Ethics of Pharmaceutical Industry Gift-Giving.

Published in:

American Journal of Bioethics, 2010, v. 10, n. 10, p. 11, doi. 10.1080/15265161.2010.519226

By:

Katz, Dana;
Caplan, ArthurL.;
Merz, JonF.

Publication type:

Article

Code of ethics for the national pharmaceutical system: Codifying and compilation.

Published in:

Journal of Research in Medical Sciences, 2013, v. 18, n. 5, p. 442

By:

Salari, Pooneh;
Namazi, Hamidreza;
Abdollahi, Mohammad;
Khansari, Fatemeh;
Nikfar, Shekoufeh;
Larijani, Bagher;
Araminia, Behin

Publication type:

Article

SEX, LIES & PHARMACEUTICALS: HOW DRUG COMPANIES PLAN TO PROFIT FROM FEMALE SEXUAL DYSFUNCTION.

Published in:

2013

By:

VAN DAALEN-SMITH, CHERYL

Publication type:

Book Review

Bioethical accreditation or rating needed to restore trust in pharma.

Published in:

Nature Medicine, 2013, v. 19, n. 3, p. 261, doi. 10.1038/nm0313-261

By:

Miller, Jennifer E.

Publication type:

Article

Conflicts of interest and the quality of recommendations in clinical guidelines .

Published in:

Journal of Evaluation in Clinical Practice, 2013, v. 19, n. 4, p. 674, doi. 10.1111/jep.12016

By:

Cosgrove, Lisa;
Bursztajn, Harold J.;
Erlich, Deborah R.;
Wheeler, Emily E.;
Shaughnessy, Allen F.

Publication type:

Article

Ethics, Pricing and the Pharmaceutical Industry.

Published in:

Journal of Business Ethics, 1992, v. 11, n. 8, p. 617, doi. 10.1007/BF00872273

By:

Spinello, Richard A.

Publication type:

Article

Alleged Unethical Behaviors and Schering-Plough.

Published in:

Strategic Finance, 2001, v. 83, n. 1, p. 18

By:

Verschoor, Curtis C.

Publication type:

Article

Pharma slips over recent failings.

Published in:

Chemistry & Industry, 2008, n. 19, p. 9

By:

Dorey, Emma

Publication type:

Article

Were study's findings misleading?

Published in:: Medical Ethics Advisor, 2016, v. 32, n. 1, p. 10
Publication type:: Article

Publicidad y promoción de medicamentos: regulaciones y grado de acatamiento en cinco países de América Latina.

Published in:

Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2011, v. 29, n. 2, p. 76, doi. 10.1590/S1020-49892011000200002

By:

Vacca, Claudia;
Vargas, Claudia;
Cañás, Martín;
Reveiz, Ludovic

Publication type:

Article

PHARMACISTS' PERCEPTION OF PHARMACEUTICAL REPRESENTATIVES' PRACTICES OF DRUG PROMOTION IN NORTH-EASTERN ROMANIA.

Published in:

Social Research Reports, 2015, v. 27, p. 26

By:

IORGA, Magdalena;
SOPONARU, Camelia;
SZTANKOVSZKY, Laszlo-Zoltan;
GAVRILOVICI, Cristina

Publication type:

Article

Pricing for Orphan Drugs.

Published in:

2013

By:

O'Sullivan, Brian P.;
Orenstein, David M.;
Milla, Carlos E.

Publication type:

Opinion

Reviews. Deadly Medicines and Organised Crime -- How Big Pharma Has Corrupted Healthcare.

Published in:

2015

By:

Cornock, Marc

Publication type:

Book Review

Study highlights influence of drug company gifts.

Published in:: 2012
Publication type:: Proceeding

Deadly Medicines and Organised Crime -- How Big Pharma Has Corrupted Healthcare.

Published in:

2015

By:

Cornock, Marc

Publication type:

Book Review

Blood on our hands: seeing the evil in inappropriate comparators.

Published in:

Journal of the Royal Society of Medicine (Supplement), 2013, v. 106, n. 1, p. 1, doi. 10.1177/0141076813476847

By:

Abbasi, Kamran

Publication type:

Article

From Javanese Coca to Java Coca.

Published in:

Technology & Culture, 2013, v. 54, n. 1, p. 90, doi. 10.1353/tech.2013.0045

By:

VAN DER HOOGTE, ARJO ROERSCH;
PIETERS, TOINE

Publication type:

Article

Withholding Information on Unapproved Drug Marketing Applications: The Public Has a Right to Know.

Published in:

Journal of Law, Medicine & Ethics, 2017, v. 45, p. 46, doi. 10.1177/1073110517750621

By:

Almashat, Sammy;
Carome, Michael

Publication type:

Article

Curing the Disobedient Patient: Medication Adherence Programs as Pharmaceutical Marketing Tools.

Published in:

Journal of Law, Medicine & Ethics, 2014, v. 42, n. 4, p. 492, doi. 10.1111/jlme.12170

By:

Lamkin, Matt;
Elliott, Carl

Publication type:

Article

From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians.

Published in:

Journal of Law, Medicine & Ethics, 2013, v. 41, n. 3, p. 673, doi. 10.1111/jlme.12077

By:

Landa, Amy Snow;
Elliott, Carl

Publication type:

Article

"Institutional Corruption" Defined.

Published in:

Journal of Law, Medicine & Ethics, 2013, v. 41, n. 3, p. 553, doi. 10.1111/jlme.12063

By:

Lessig, Lawrence

Publication type:

Article

Effect of Financial Relationships on the Behaviors of Health Care Professionals: A Review of the Evidence.

Published in:

Journal of Law, Medicine & Ethics, 2012, v. 40, n. 3, p. 452, doi. 10.1111/j.1748-720X.2012.00678.x

By:

Robertson, Christopher;
Rose, Susannah;
Kesselheim, Aaron S.

Publication type:

Article

Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform.

Published in:

Journal of Law, Medicine & Ethics, 2012, v. 40, n. 3, p. 511, doi. 10.1111/j.1748-720X.2012.00683.x

By:

Rodwin, Marc A.

Publication type:

Article

Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil.

Published in:

Journal of Law, Medicine & Ethics, 2012, v. 40, n. 3, p. 673, doi. 10.1111/j.1748-720X.2012.00698.x

By:

Tomljenovic, Lucija;
Shaw, Christopher A.

Publication type:

Article

INTRODUCTION: Pharmaceutical Firms and the Right to Health.

Published in:

Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 183, doi. 10.1111/j.1748-720X.2012.00656.x

By:

de Campos, Thana Cristina;
Pogge, Thomas

Publication type:

Article

Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.

Published in:

Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 234, doi. 10.1111/j.1748-720X.2012.00661.x

By:

Grover, Anand;
Citro, Brian;
Mankad, Mihir;
Lander, Fiona

Publication type:

Article

Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.

Published in:

Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 220, doi. 10.1111/j.1748-720X.2012.00660.x

By:

Lee, Joo-Young;
Hunt, Paul

Publication type:

Article

Pharmaceutical Companies vs. the State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil?

Published in:

Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 188, doi. 10.1111/j.1748-720X.2012.00657.x

By:

Wang, Daniel Wei L.;
Ferraz, Octavio Luiz Motta

Publication type:

Article

Pharmaceutical Speakers' Bureaus, Academic Freedom, and the Management of Promotional Speaking at Academic Medical Centers.

Published in:

Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 311, doi. 10.1111/j.1748-720X.2012.00666.x

By:

Boumil, Marcia M.;
Cutrell, Emily S.;
Lowney, Kathleen E.;
Berman, Harris A.

Publication type:

Article

Damned If You Do, Damned If You Don't? The Lundbeck Case of Pentobarbital, the Guiding Principles on Business and Human Rights, and Competing Human Rights Responsibilities.

Published in:

Journal of Law, Medicine & Ethics, 2012, v. 40, n. 2, p. 206, doi. 10.1111/j.1748-720X.2012.00659.x

By:

Buhmann, Karin

Publication type:

Article

Атестація та безперервна освіта провізорів

Published in:

Hileya: Scientific Bulletin / Gileya, 2017, n. 126, p. 423

By:

Струк, О. А.

Publication type:

Article

Drug companies should report clinical trial results, even when they won't lead to a product.

Published in:: Formulary, 2011, v. 46, n. 10, p. 404
Publication type:: Article

Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising.

Published in:

Journal of Business Ethics, 2014, v. 123, n. 1, p. 145, doi. 10.1007/s10551-013-1805-0

By:

Biegler, Paul

Publication type:

Article

Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?

Published in:

Journal of Business Ethics, 2010, v. 94, n. 2, p. 211, doi. 10.1007/s10551-009-0257-z

By:

Pol, Pepijn;
Bakker, Frank

Publication type:

Article

Patently Innovative: How Pharmaceutical Firms Use Emerging Patent Law to Extend Monopolies on Blockbuster Drugs and Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries.

Published in:

Journal of Legal Medicine, 2013, v. 34, n. 1, p. 149, doi. 10.1080/01947648.2013.768509

By:

Lee, StaceyB.

Publication type:

Article

Silence Is Not the Best Medicine: Requiring Disclosure of Clinical Trial Data for Abandoned Drugs.

Published in:

Journal of Legal Medicine, 2012, v. 33, n. 4, p. 571, doi. 10.1080/01947648.2012.739072

By:

Powell, Brandon

Publication type:

Article

An Ethical Dilemma.

Published in:

Journal of Legal Medicine, 2012, v. 33, n. 1, p. 115, doi. 10.1080/01947648.2012.657939

By:

Blasi, AlexandraE.

Publication type:

Article

PRICELESS GOODS: HOW SHOULD LIFE-SAVING DRUGS BE PRICED?

Published in:

Business Ethics Quarterly, 2002, v. 12, n. 4, p. 451, doi. 10.2307/3857995

By:

Maitland, Ian

Publication type:

Article

Bad Pharma.

Published in:

2013

By:

Crowley, Dennis

Publication type:

Book Review

Financial Toxicity of Cancer Drugs: Possible Remedies from an Ethical Perspective.

Published in:

Breast Care, 2017, v. 12, n. 2, p. 81, doi. 10.1159/000471506

By:

Marckmann, Georg;
der Schmitten, Jürgen in

Publication type:

Article

Addressing common legal and ethical concerns with off-label prescribing in Australia.

Published in:

Australian Medical Student Journal, 2012, v. 3, n. 1, p. 70

By:

Bennett, Michael J.

Publication type:

Article